Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2986 to 3000 of 7685 results

  1. Modern slavery and human trafficking statement

    Read NICE's statement on modern slavery and human trafficking

  2. Patient safety

    Our guidelines make evidence based, best practice recommendations. These help to improve patient safety and reduce the risk of harm across the health system.

  3. Reusing our content

    How to use our content for your own purpose. Reuse our guidance, advice, collections and documents.

  4. Medical technologies advisory committee members

    Find out more about the medical technologies advisory committee members by reading their biographies. Dr Jacob Brown (chair) Biography Jacob

  5. Cookies

    How NICE uses cookies and how you can manage them.

  6. Shared learning case studies

    Working examples of quality improvement in health and social care services. Quality improvement, efficiency changes, cost savings, good practice, shared learning.

  7. Diabetes: NDH annual HbA1c or FPG test (IND172)

    This indicator covers the percentage of patients with non-diabetic hyperglycaemia who have had an HbA1c test or FPG test in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM150

  8. Autism: register (IND175)

    This indicator covers establishing and maintaining a register of all patients on the autistic spectrum. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM153

  9. Diabetes: gestational diabetes annual HbA1c test (IND173)

    This indicator covers the percentage of women who have had gestational diabetes, diagnosed more than 12 months ago, who have had an HbA1c test in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM151

  10. Diabetes: NDH register (IND170)

    This indicator covers the establishing and maintaining of a register of all patients with a diagnosis of non-diabetic hyperglycaemia. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM148

  11. Immunisation: flu vaccine for people with stroke or TIA (IND164)

    This indicator covers the percentage of patients with stroke or TIA who have had influenza immunisation in the preceding 1 August to 31 March. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM140

  12. Immunisation: flu vaccine for people with diabetes (IND163)

    This indicator covers the percentage of patients with diabetes, on the register, who have had influenza immunisation in the preceding 1 August to 31 March. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM139

  13. Weight management: BMI recording (long-term conditions) (IND151)

    This indicator covers the percentage of patients with coronary heart disease, stroke or TIA, diabetes, hypertension, peripheral arterial disease, heart failure, COPD, asthma and/or rheumatoid arthritis who have had a BMI recorded in the preceding 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM121

  14. Diabetes: NDH diabetes prevention programme (IND171)

    This indicator covers the percentage of patients newly diagnosed with non-diabetic hyperglycaemia in the preceding 12 months who have been referred to a Healthier You: NHS Diabetes Prevention Programme for intensive lifestyle advice. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM149

  15. Immunisation: DTaP/IPV and MMR (5 years) (IND217)

    This indicator covers the percentage of children who have reached 5 years old in the preceding 12 months, who have received a reinforcing dose of DTaP/IPV and at least 2 doses of MMR between the ages of 1 and 5 years. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM199